aTyr Pharma, Inc. ATYR
0.31
(0.03)
(8.82%)
as of 25 Sep
- Market cap
- $31.4M
- P/E
- 0.0×
Follow ATYR
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | 0.00 | 3.40 | — | 5.25 | 6.21 | 20.64 | 6.50 |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | (2.85) | (6.58) | — | (6.47) | (7.27) | (20.47) | (5.95) |
P/B ratio |
— | — | — | 0.67 | 1.13 | — | 0.94 | 0.89 | 3.85 | 1.08 |
Price to Tangible BV |
— | — | — | 0.67 | 1.13 | — | 0.94 | 0.89 | 3.85 | 1.08 |
EV/Sales |
— | — | — | 0.00 | 0.58 | — | 0.22 | (1.17) | 15.26 | (0.42) |
EV/EBITDA |
— | — | — | 0.26 | 0.00 | — | 0.00 | 0.27 | 0.00 | 0.06 |
EV/Operating CF |
— | — | — | 0.27 | (0.40) | — | (0.07) | 0.45 | (2.88) | 0.08 |
EV/FCF |
— | — | — | 0.27 | (0.39) | — | (0.07) | 0.40 | (2.87) | 0.08 |
Quick Ratio |
8.46 | 8.19 | 4.57 | 2.42 | 5.75 | 18.02 | 5.62 | 6.13 | 4.93 | 5.25 |
Current Ratio |
8.77 | 8.37 | 4.69 | 2.47 | 6.06 | 18.89 | 5.83 | 6.27 | 5.48 | 5.30 |
Net Debt/EBITDA |
1.11 | 1.43 | 1.07 | 0.92 | 2.08 | 3.29 | 1.45 | 1.75 | 1.03 | 1.01 |
Debt/Assets |
11.84% | 22.08% | 30.39% | 32.42% | 5.78% | 1.19% | 1.98% | 1.18% | 0.92% | 0.28% |
Debt/Equity |
0.15 | 0.31 | 0.48 | 0.56 | 0.07 | 0.01 | 0.03 | 0.02 | 0.01 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.01 | 0.28 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.91 | 0.88 | 0.90 | 0.85 | 0.94 | 0.98 | 0.92 | 0.66 | 1.08 | 0.84 |
Capex/Depreciation |
(0.37) | (1.00) | (0.41) | (0.02) | (0.11) | (0.08) | (0.66) | 9.77 | 0.05 | 0.22 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (65.06%) | (75.89%) | (70.52%) | (86.34%) | (61.80%) | (48.03%) | (50.26%) | (62.30%) | (79.88%) | (108.11%) | |
| (55.05%) | (56.75%) | (48.58%) | (53.08%) | (43.31%) | (43.78%) | (42.91%) | (46.56%) | (58.88%) | (78.09%) | |
ROIC |
(18,959.42%) | 0.00% | (15,194.44%) | (890.34%) | (488.91%) | (819.88%) | (412.03%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(85.50%) | (61.12%) | (82.53%) | (116.43%) | (53.08%) | (31.24%) | (64.71%) | (54.71%) | (89.12%) | (106.87%) |
Average Days of Receivables |
— | — | — | 86.49 | 71.18 | 0.00 | 413.81 | 2,518.81 | 2,696.34 | 1,677.08 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 3,328.91% | 165.38% | 0.00% | 412.17% | 11,981.02% | 23,137.02% | 31,694.21% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 2,216.11% | 86.80% | 0.00% | 134.62% | 3,676.77% | 5,862.55% | 9,262.11% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 422.51% | 14.01% | 0.00% | 20.74% | 736.54% | 1,271.91% | 2,630.00% |
Graham Net Nets |
— | — | — | 1.20 | 0.80 | — | 0.84 | 0.91 | 0.20 | 0.75 |
Graham Number |
— | — | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | (175.80%) | (40.98%) | — | (67.80%) | (64.00%) | (24.03%) | (101.28%) |
Free Cash Flow Yield |
— | — | — | (143.22%) | (43.57%) | — | (64.63%) | (46.54%) | (25.73%) | (85.58%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.13 | 1.14 | 0.00 | 0.37 | 0.01 | 0.00 | 0.00 |
Operating CF per Share |
(31.26) | (22.96) | (14.50) | (5.96) | (1.67) | (1.73) | (1.47) | (0.62) | (0.93) | (0.67) |
Capex per Share |
(0.35) | (0.71) | (0.28) | (0.01) | (0.02) | (0.01) | (0.05) | (0.08) | 0.00 | 0.00 |
Free Cash Flow per Share |
(31.62) | (23.67) | (14.78) | (5.97) | (1.69) | (1.74) | (1.53) | (0.70) | (0.93) | (0.67) |
Cash per Share |
42.67 | 46.14 | 23.13 | 9.28 | 3.46 | 5.66 | 2.33 | 1.83 | 0.97 | 0.85 |
Shareholders Equity per Share |
37.14 | 34.82 | 15.71 | 6.27 | 3.44 | 5.72 | 2.51 | 1.69 | 0.94 | 0.72 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
37.14 | 34.82 | 15.71 | 6.27 | 3.44 | 5.72 | 2.51 | 1.69 | 0.94 | 0.72 |
Free Cash Flow |
(53.46) | (43.68) | (31.66) | (20.04) | (15.48) | (33.22) | (43.35) | (37.42) | (69.18) | (62.05) |
Working Capital |
66.24 | 76.59 | 39.97 | 19.00 | 29.67 | 107.56 | 67.01 | 86.58 | 66.99 | 65.09 |
Capital Expenditures |
(0.60) | (1.31) | (0.59) | (0.03) | (0.18) | (0.14) | (1.46) | (4.20) | (0.06) | (0.06) |
Net Current Asset Value |
57.05 | 61.88 | 31.71 | 16.76 | 28.29 | 107.16 | 56.37 | 72.81 | 54.96 | 54.52 |
EV/EBIT |
— | — | — | 0.24 | 0.00 | — | 0.00 | 0.27 | 0.00 | 0.06 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.07 | 0.02 | 0.00 | 0.14 | 11.90 | 0.25 | 0.34 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | (5,593.13%) | (155.18%) | 0.00% | (436.53%) | (14,274.50%) | (27,243.83%) | (39,009.47%) |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.13 | 0.58 | 0.78 | 1.41 | 1.92 | 3.08 | 0.73 | (0.08) | (0.24) | (0.07) |
Cash ROIC |
(37.57%) | (26.40%) | (33.17%) | (33.31%) | (24.77%) | (15.39%) | (32.26%) | (20.39%) | (51.78%) | (45.30%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | 9.78 | 0.00 | 1.70 | 0.05 | 0.11 | 0.15 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 | — | — | — |
Average Receivables |
— | — | — | 348.66 | 1.07 | 1.24 | 6.11 | 7.11 | 2.09 | 1.30 |
Average Payables |
3.24 | 2.44 | 1.66 | 0.94 | 1.14 | 1.23 | 2.07 | 3.32 | 3.93 | 4.11 |
Average Assets |
105.10 | 84.94 | 71.05 | 44.47 | 37.46 | 77.13 | 105.66 | 108.22 | 108.74 | 94.92 |
Average Common Equity |
88.93 | 63.52 | 48.95 | 27.34 | 26.25 | 70.31 | 90.21 | 80.88 | 80.15 | 68.56 |
Columns are period end dates